1. PI3K/Akt/mTOR
  2. mTOR
  3. JR-AB2-011

JR-AB2-011 

Cat. No.: HY-122022 Purity: 98.09%
Handling Instructions

JR-AB2-011 is a selective mTORC2 inhibitor with an IC50 value of 0.36 μM. JR-AB2-011 inhibits mTORC2 activity by blocking Rictor-mTOR association (Ki: 0.19 μM). JR-AB2-011 has anti-glioblastoma multiforme (GBM) properties.

For research use only. We do not sell to patients.

JR-AB2-011 Chemical Structure

JR-AB2-011 Chemical Structure

Size Price Stock Quantity
10 mM * 1 mL in DMSO USD 286 In-stock
Estimated Time of Arrival: December 31
5 mg USD 260 In-stock
Estimated Time of Arrival: December 31
10 mg USD 440 In-stock
Estimated Time of Arrival: December 31
25 mg USD 940 In-stock
Estimated Time of Arrival: December 31
50 mg USD 1600 Get quote
100 mg USD 2600 Get quote
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Customer Review

Top Publications Citing Use of Products

View All mTOR Isoform Specific Products:

  • Biological Activity

  • Technical Information

  • Purity & Documentation

  • References

Description

JR-AB2-011 is a selective mTORC2 inhibitor with an IC50 value of 0.36 μM. JR-AB2-011 inhibits mTORC2 activity by blocking Rictor-mTOR association (Ki: 0.19 μM). JR-AB2-011 has anti-glioblastoma multiforme (GBM) properties[1].

IC50 & Target[1]

mTORC2

0.36 μM (IC50)

In Vitro

JR-AB2-011 (1 μM; 24 hours) has good anti-GBM properties, blocks mTORC2 signaling and Rictor association with mTOR[1].
JR-AB2-011 (0.5-2 μM; 48 hours) displays the least toxicity to normal neurons with no significant cytotoxic effects for concentrations up to 10 mM compared to CID613034[1].

Apoptosis Analysis[1]

Cell Line: U87 GBM cells; LN229 GBM cells
Concentration: 1 μM
Incubation Time: 24 hours
Result: Had good anti-GBM properties and blocked mTORC2 signaling and Rictor association with mTOR.

Cell Cytotoxicity Assay[1]

Cell Line: Normal mature human neurons
Concentration: 0.5, 1, 2 μM
Incubation Time: 48 hours
Result: Displayed the least toxicity to normal neurons with no significant cytotoxic effects for concentrations up to 10 mM.
In Vivo

Mice receiving JR-AB2-011 (4 mg/kg; daily i.p. for 10 days; 20 mg/kg; daily i.p. for 10 days) at either dosing regimen display marked inhibition of tumor growth rate (JR-AB2-011 at 4 mg/kg/d; 74% inhibition at end of dosing period; tumor growth delay 10.0 days; JR-AB2-011 at 20 mg/kg/d; 80% inhibition at end of dosing period; tumor growth delay 12.0 days) as compared to mice receiving vehicle alone[1].

Animal Model: LN229 cells in female C.B.-17-scid (Taconic) mice[1]
Dosage: 4 mg/kg; 20 mg/kg
Administration: Daily i.p.; 10 days
Result: Either dosing regimen displayed marked inhibition of tumor growth rate as compared to mice receiving vehicle alone.
References
Molecular Weight

398.28

Formula

C₁₇H₁₄Cl₂FN₃OS

SMILES

ClC1=C(Cl)C=C(NC(N2/C(SC(C)C2)=N/C3=CC=C(F)C=C3)=O)C=C1

Storage

4°C, protect from light

Shipping

Room temperature in continental US; may vary elsewhere

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number *

 

Organization name *

Country or Region *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
JR-AB2-011
Cat. No.:
HY-122022
Quantity:

JR-AB2-011

Cat. No.: HY-122022